Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: The roles of surgery and chemotherapy

Gynecologic Oncology

Volumn 103, Issue 1, 2006, Pages 120-126

  von Gruenigen, Vivian E ^a,b   Frasure, Heidi E ^a,b   Jenison, Eric L ^c,d   Hopkins, Michael P ^c,d   Gil, Karen M ^c,d  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Northeastern Ohio Medical University   (United States)

^d AKRON GENERAL MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Complementary and alternative medicine; Gynecologic oncology; Ovarian cancer; Quality of life; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CLINICAL ARTICLE; EMOTION; FEMALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY; FUNCTIONAL STATUS; HUMAN; LIFESTYLE; NON INVASIVE MEASUREMENT; OVARY CANCER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; WELLBEING;

COHORT STUDIES; COMBINED MODALITY THERAPY; COMPLEMENTARY THERAPIES; DIET; EXERCISE; FEMALE; HUMANS; LIFE STYLE; LONGITUDINAL STUDIES; MIDDLE AGED; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 33748527248     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.01.059     Document Type: Article

References (37)

1. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghaffor A., et al. Cancer Statistics 2005. CA Cancer J. Clin. 55 (2005) 10-30
2. Lakusta C.M., Atkinson M.J., Robinson J.W., Nation J., Taenzer P.A., and Campo M.G. Quality of life in ovarian cancer patients receiving chemotherapy. Gynecol. Oncol. 81 (2001) 490-495
3. Schink J.C., Weller E., Harris L.S., Cella D., Gerstner J., Falkson C., et al. Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: An eastern cooperative oncology group phase II study (E2E93). J. Cancer 7 (2001) 155-164
4. Butler L., Bacon M., Carey M., Zee B., Tu D., and Bezjak A. Determining the relationship between toxicity and quality of life in an ovarian cancer chemotherapy clinical trial. J. Clin. Oncol. 22 (2004) 2461-2468
5. Le T., Hopkins L., Kee M., and Fung F. Quality of life assessment during adjuvant and salvage chemotherapy for advance stage epithelial ovarian cancer. Gynecol. Oncol. 98 (2005) 39-44
6. Blanchard C.M., Denniston M.M., Baker F., Ainsworth S.R., Courneya K.S., Hann D.M., et al. Do adults change their lifestyle behaviors after a cancer diagnosis?. Am. J. Health Behav. 27 (2003) 246-256
7. Rock C.L., and Demark-Wahnefried W. Can lifestyle modification increase survival in women diagnosed with breast cancer?. J. Nutr. 132 (2002) 3504S-3507S (Suppl)
8. Ernst E., and Cassileth B.R. The prevalence of complementary/alternative medicine in cancer. A systematic review. Cancer 83 (1998) 777-782
9. von Gruenigen V.E., White L.J., Kirven M.S., Showalter A.L., Hopkins M.P., and Jenison E.J. A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients. Int. J. Gynecol. Cancer 11 (2001) 205-209
10. Richardson M.A., Sanders T., Palmer J.L., Greisinger A., and Singletary S.E. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J. Clin. Oncol. 18 (2000) 2505-2514
11. DiGianni L.M., Garber J.E., and Winer E.P. Complementary and alternative medicine use among women with breast cancer. J. Clin. Oncol. 20 (2002) 34S-38S (Suppl)
12. Gil K.M., Frasure H.E., Hopkins M.P., Jenison E.J., and von Gruenigen V.E. Effect of method of administration on longitudinal assessment of quality of life in gynecologic cancer: An exploratory study. Health Qual. Life Outcomes 3 (2005) 6
13. Cella D.F., Tulsky D.S., Gray G., Sarafian B., Linn E., Bonomi A., et al. The functional assessment of cancer therapy scale: Development and validation of the general measure. J. Clin. Oncol. 11 (1993) 570-579
14. Webster K., Cella D., and Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual. Life Outcomes 1 (2003) 79
15. Yellen S.B., Cella D.F., Webster K., Blendowski C., and Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J. Pain Symptom Manage 13 (1997) 63-74
16. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 30 (1992) 473-483
17. Cohen H.J., Feussner J.R., Weinberger M., Carnes M., Hamdy R.C., Hsieh F., et al. A controlled trial of inpatient and outpatient geriatric evaluation and management. N. Engl. J. Med. 346 (2002) 905-912
18. Thompson F.E., Kipnis V., Subar A.F., Krebs-Smith S.M., Kahle L.L., Midthune D., et al. Evaluation of 2 brief instruments and a food-frequency questionnaire to estimate daily number of servings of fruit and vegetables. Am. J. Clin. Nutr. 71 (2000) 1503-1510
19. Thompson F.E., Subar A.F., Smith A.F., Midthune D., Radimer K.L., Kahle L.L., et al. Fruit and vegetable assessment: performance of 2 new short instruments and a food frequency questionnaire. J. Am. Diet. Assoc. 102 (2002) 764-772
20. Fruit and vegetable screeners: Instruments. National Cancer Institute. U.S. National Institutes of Health (http://www.riskfactor.cancer.gov/diet/screeners/fruitveg/instrument).
21. Peters J.R., Quiter E.S., Brekke M.L., Admire J., Brekke M.J., Mullis R.M., et al. The eating pattern assessment tool: A simple instrument for assessing dietary fat and cholesterol intake. J. Am. Diet. Assoc. 94 (1994) 1008-1013
22. Kornblith A.B., Thaler H.T., Wong G., Vlamis V., Lepore J.M., Loseth D.B., et al. Quality of life of women with ovarian cancer. Gynecol. Oncol. 59 (1995) 231-242
23. Bodurka-Bevers D., Basen-Engquist K., Carmack C.L., Fitzgerald M.A., Wolf J.K., de Moor C., et al. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol. Oncol. 78 (2000) 302-308
24. Sprangers M.A.G., and Schwartz C.E. The challenge of response shift for quality-of-life based clinical oncology research. Ann. Oncol. 10 (1999) 747-749
25. Lutgendorf S.K., Anderson B., Ullrich P., Johnsen E.L., Buller R.E., Sood A.K., et al. Quality of life and mood in women with gynecologic cancer: A one-year prospective study. Cancer 94 (2002) 131-140
26. Greimel E., Thiel I., Peintinger F., Cegnar I., and Pongratz E. Prospective assessment of quality of life of female cancer patients. Gynecol. Oncol. 85 (2002) 140-147
27. Bezjak A., Tu P., Bacon M., Osoba D., Zee B., Stuart G., et al. Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study. J. Clin. Oncol. 22 (2004) 4595-4603
28. von Gruenigen V.E., Gil K.M., Frasure H.E., Jenison E.J., and Hopkins M.P. The impact of obesity and age on quality of life in gynecologic surgery. Amer. J. Obstet. Gynecol. 193 (2005) 1369-1375
29. Dy G.K., Bekele L., Hanson L.J., Furth A., Mandrekar S., Sloan J.A., et al. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J. Clin. Oncol. 22 (2004) 4758-4763
30. Swisher E.M., Cohn D.E., Goff B.A., Parham J., Herzog T.J., Rader J.S., et al. Use of complementary and alternative medicine among women with gynecologic cancers. Gynecol. Oncol. 84 (2002) 363-367
31. Navo M.A., Phan J., Vaughan C., Palmer J.L., Michaud L., Jones K.L., et al. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J. Clin. Oncol. 22 (2004) 671-677
32. Patterson R.E., Neuhouser M.L., Hedderson M.M., Schwartz S.M., Standish L.J., and Bowen D.J. Changes in diet, physical activity, and supplement use among adults diagnosed with cancer. J. Am. Diet. Assoc. 103 (2003) 323-328
33. Maunsell E., Drolet M., Brisson J., Robert J., and Deschenes L. Dietary change after breast cancer: extent, predictors, and relation with psychological distress. J. Clin. Oncol. 20 (2002) 1017-1025
34. Pinto B.M., Maruyama N.C., Clark M.M., Cruess D.G., Park E., and Roberts M. Motivation to modify lifestyle risk behaviors in women treated for breast cancer. Mayo Clin. Proc. 77 (2002) 122-129
35. Demark-Wahnefried W., Peterson B.L., Winer E.P., Marks L., Aziz N., Marcom P.K., et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J. Clin. Oncol. 19 (2001) 2381-2389
36. Harvie M.N., Campbell I.T., Baildam A., and Howell A. Energy balance in early breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res. Treat. 83 (2004) 201-210
37. Basen-Engquist K., Bodurka-Bevers D., Fitzgerald M.A., Webster K., Cella D., Hu S., et al. Reliability and validity of the functional assessment of cancer therapy-ovarian. J. Clin. Oncol. 19 (2001) 1809-1817